New Key Statistics Module, Z-Score and F-Score
XMAD:MED Key Ratios
| Market Cap € M | 11.12 |
| Enterprise Value € M | 15.40 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 9,999.00 |
| Forward PE Ratio | -- |
| Price/Book | 11.03 |
| Price/Sales | 0.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 22.00 |
| EPS (TTM) € | -0.06 |
| Beneish M-Score | -2.38 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 25.00 |
| EV-to-EBIT | 103.38 |
| EV-to-EBITDA | 13.31 |
| PEG | -- |
| Shares Outstanding M | 12.92 |
| Net Margin (%) | -3.48 |
| Operating Margin % | 3.70 |
| Pre-tax Margin (%) | -3.91 |
| Quick Ratio | 0.89 |
| Current Ratio | 1.44 |
| ROA % (ttm) | -2.83 |
| ROE % (ttm) | -41.59 |
| ROIC % (ttm) | 4.78 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.26 |
XMAD:MED Number of Guru Trades
XMAD:MED Volume of Guru Trades
Gurus Latest Trades with XMAD:MED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XMAD:MED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers